Gardner Lewis Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-51,703
Closed -$569K 126
2017
Q3
$569K Sell
51,703
-1,586,096
-97% -$17.4M 0.04% 98
2017
Q2
$17.9M Buy
+1,637,799
New +$18M 1.19% 20

Gardner Lewis Asset Management's ELOS Position: Q4 2017 in Review

Gardner Lewis Asset Management sold out of Syneron Medical Ltd (ELOS) in Q4 2017, closing a stake of 51,703 shares — an estimated $569K sold.

Gardner Lewis Asset Management first reported a position in ELOS in Q2 2017 and held it in 2 quarters. The position peaked at $17.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds ELOS as of Q4 2017.

  • Gardner Lewis Asset Management reported no remaining Syneron Medical Ltd position as of Q4 2017 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 51,703 Syneron Medical Ltd shares in Q4 2017, an estimated $569K.
  • Gardner Lewis Asset Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 2 quarters.
  • Gardner Lewis Asset Management's Syneron Medical Ltd position peaked at $17.9M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2017.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.